STL Volume 28 Number 4

STL Volume 28 Number 4
3 POSTS 0 COMMENTS
Purchase PDF for $2.79
Daxxify injection being done on woman's forehead

DaxibotulinumtoxinA-lanm (Daxxify™): A Comprehensive Overview

DAXI's innovative biochemical composition, replacing HSA with the peptide RTP004, enhances its efficacy, safety, and duration, potentially using less core neurotoxin, positioning it as a groundbreaking botulinum toxin A (BoNTA) for dynamic facial lines treatment.
patient looking at medication in a pharmacy (presumably for treating shingles)

Prevention of Shingles in Dermatology Patients on Systemic Medications

Dermatologists should be proactive in recommending RZV to all patients over age 50 years, particularly those with a family history of zoster and diseases with altered immune function. Adult patients who are immunocompromised because of their diseases or treatment (e.g., systemic steroids, JAK inhibitors, combination biologic/conventional disease-modifying antirheumatics), should also be encouraged.
abstract image of various pills and researcher holding a pill

Update on Drugs & Devices: July – August 2023

Update on Roflumilast cream 0.3% (Zoryve™), Adalimumab-aaty SC use (Yuflyma®), Beremagene geperpavec-svdt topical gene therapy (Vyjuvek™), Molecular imaging device (Orlucent®), Tirbanibulin ointment 1% w/w (Onakta™), Pegunigalsidase alfaiwxj for IV use (Elfabrio®), Autologous cell harvesting device (Recell® System), and Odevixibat capsules/pellets (Bylvay®).

POPULAR

Advertisement